Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEG 3350 vs Prucalopride in Chronic Constipation
NCT01251822Phase 3Completed
- Sponsor
- Norgine
- Start
- Nov 2010
- Primary completion
- Sep 2011
- Modality
- Injectable Hydrogels, Implantable Hydrogels, Biodegradable Polymers
- Countries
- 1
01
Overview
A Phase 3 trial of polyethylene glycol 3350 in chronic constipation, sponsored by Norgine. Started Nov 2010; status: completed.
02
Drugs
polyethylene glycol 3350
03
Conditions
chronic constipation
Beyond the preview
Go deeper on NCT01251822.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01251822.